We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Validation of MMS Test for Cancer Monitoring (MMS-TM)

This study is currently recruiting participants.
Verified March 2016 by MedInnovation GmbH
Sponsor:
ClinicalTrials.gov Identifier:
NCT02113683
First Posted: April 15, 2014
Last Update Posted: March 13, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
HELIOS Klinikum Berlin-Buch
Information provided by (Responsible Party):
MedInnovation GmbH
  Purpose
The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Condition
Colo-rectal Cancer Stomach Cancer Melanoma Sarcoma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods

Resource links provided by NLM:


Further study details as provided by MedInnovation GmbH:

Primary Outcome Measures:
  • active tumor growth before and after cancer therapy [ Time Frame: up to 36 month ]

Estimated Enrollment: 100
Study Start Date: May 2014
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
MMS test
therapy monitoring of patients with colo-rectal or stomach disease or with melanoma

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients with primary diagnosis of cancer
Criteria

Inclusion Criteria:

  • Clinical diagnosis of colo-rectal cancer
  • Clinical diagnosis of stomach cancer
  • Suspected diagnosis of melanoma

Exclusion Criteria:

  • Colitis ulcerosa
  • Morbus Crohn
  • Cancer in time period two years before
  • Cancer therapy in time period two years before
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02113683


Contacts
Contact: Peter Reichardt, Dr. med. +49 30 9401 548 00 peter.reichardt@helios-kliniken.de

Locations
Germany
HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie Recruiting
Berlin, Germany, 13125
Contact: Peter Reichardt, Dr. med.    +49 30 9401 548 00    peter.reichardt@helios.kliniken.de   
Sponsors and Collaborators
MedInnovation GmbH
HELIOS Klinikum Berlin-Buch
Investigators
Principal Investigator: Katja Waterstradt, PhD MedInnovation GmbH
  More Information

Responsible Party: MedInnovation GmbH
ClinicalTrials.gov Identifier: NCT02113683     History of Changes
Other Study ID Numbers: MMS-tm14
First Submitted: April 8, 2014
First Posted: April 15, 2014
Last Update Posted: March 13, 2017
Last Verified: March 2016

Keywords provided by MedInnovation GmbH:
colo-rectal cancer
stomach cancer
melanoma
MMS test
therapy monitoring
Sarcoma

Additional relevant MeSH terms:
Melanoma
Sarcoma
Rectal Neoplasms
Stomach Neoplasms
Colorectal Neoplasms
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas
Neoplasms, Connective and Soft Tissue
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases
Stomach Diseases
Colonic Diseases